| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ALMR
Alamar Biosciences, Inc.
|
Jul 15, 2026 | BUY |
Strong Buy
+17.6% avg upside
5 analysts
|
$34.00
29.11% Upside
|
· |
|
QGEN
Qiagen
|
Jul 15, 2026 | HOLD |
Buy
+0.9% avg upside
24 analysts
|
$44.00
5.65% Upside
|
· |
|
RVTY
Revvity
|
Jul 15, 2026 | BUY |
Buy
-4.2% avg upside
23 analysts
|
$130.00
16.94% Upside
|
-0.3% |
|
ILMN
Illumina
|
Jul 15, 2026 | HOLD |
Buy
-16.1% avg upside
30 analysts
|
$192.00
3.40% Upside
|
+0.6% |
|
BRKR
Bruker
|
Jul 15, 2026 | HOLD |
Buy
-3.5% avg upside
22 analysts
|
$60.00
1.44% Upside
|
· |
|
TEM
Tempus AI, Inc. Class A
|
Jul 15, 2026 | BUY |
Strong Buy
+17.0% avg upside
20 analysts
|
$71.00
24.58% Upside
|
-5.0% |
|
GRAL
GRAIL Inc
|
Jul 15, 2026 | BUY |
Buy
-7.5% avg upside
8 analysts
|
$88.00
18.38% Upside
|
+0.0% |
|
WGS
GeneDx Holdings
|
Jul 15, 2026 | BUY |
Strong Buy
+17.3% avg upside
9 analysts
|
$85.00
32.66% Upside
|
+0.0% |
|
TXG
10x Genomics
|
Jul 15, 2026 | HOLD |
Buy
-29.4% avg upside
18 analysts
|
$47.00
3.05% Upside
|
+0.0% |
|
ADPT
Adaptive Biotechnologies
|
Jul 15, 2026 | BUY |
Strong Buy
-3.0% avg upside
14 analysts
|
$25.00
13.04% Upside
|
· |
|
PSNL
Personalis
|
Jul 15, 2026 | BUY |
Strong Buy
-14.3% avg upside
11 analysts
|
$18.00
17.24% Upside
|
· |
|
AVTR
Avantor
|
Jul 15, 2026 | HOLD |
Buy
+29.5% avg upside
26 analysts
|
$11.00
3.11% Downside
|
+0.0% |
|
GH
Guardant Health
|
Jul 15, 2026 | BUY |
Strong Buy
-9.5% avg upside
31 analysts
|
$200.00
22.33% Upside
|
+0.0% |
|
NTRA
Natera
|
Jul 15, 2026 | BUY |
Strong Buy
-4.0% avg upside
26 analysts
|
$325.00
17.76% Upside
|
+0.0% |
|
NEO
NeoGenomics
|
Jul 15, 2026 | BUY |
Strong Buy
+12.1% avg upside
17 analysts
|
$19.00
32.68% Upside
|
· |
|
WAT
Waters
|
Jul 15, 2026 | HOLD |
Strong Buy
+1.0% avg upside
30 analysts
|
$408.00
7.96% Upside
|
+0.6% |
|
A
Agilent
|
May 27, 2026 | BUY |
Strong Buy
+10.0% avg upside
33 analysts
|
$155.00
14.51% Upside
|
+16.6% |
|
TMO
Thermo Fisher
|
May 20, 2026 | BUY |
Strong Buy
+9.8% avg upside
38 analysts
|
— | +19.0% |
|
MDXH
MDxHealth
|
May 14, 2026 | BUY |
Strong Buy
+1387.4% avg upside
8 analysts
|
$1.50
259.70% Upside
|
-55.4% |
|
XGN
Exagen
|
May 11, 2026 | BUY |
Strong Buy
+179.3% avg upside
10 analysts
|
$8.00
85.18% Upside
|
-8.5% |
|
CAI
Caris Life Sciences, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+59.8% avg upside
20 analysts
|
$31.00
81.31% Upside
|
+5.2% |
|
PACB
Pacific Biosciences
|
May 08, 2026 | BUY |
Buy
+188.3% avg upside
14 analysts
|
$3.00
94.87% Upside
|
+7.1% |
|
QTRX
Quanterix
|
May 06, 2026 | HOLD |
Buy
+352.5% avg upside
8 analysts
|
$4.00
1.90% Downside
|
+21.9% |
|
SERA
Sera Prognostics
|
May 06, 2026 | BUY |
Strong Buy
+253.6% avg upside
7 analysts
|
— | +12.7% |
|
SOPH
SOPHiA GENETICS
|
May 05, 2026 | BUY |
Strong Buy
+66.4% avg upside
7 analysts
|
— | +7.3% |
|
BDSX
Biodesix
|
May 05, 2026 | BUY |
Strong Buy
+53.8% avg upside
8 analysts
|
$30.00
43.90% Upside
|
-0.9% |
|
NAUT
Nautilus Biotechnolgy
|
Apr 28, 2026 | BUY |
Strong Buy
+560.9% avg upside
5 analysts
|
— | -32.4% |
|
DHR
Danaher
|
Apr 21, 2026 | BUY |
Strong Buy
+7.7% avg upside
45 analysts
|
$240.00
19.05% Upside
|
+2.5% |
|
SEER
Seer
|
Feb 26, 2026 | BUY |
Strong Buy
+424.7% avg upside
5 analysts
|
— | +3.9% |
|
MYGN
Myriad Genetics
|
Feb 23, 2026 | HOLD |
Hold
+194.3% avg upside
24 analysts
|
$7.00
11.73% Upside
|
+37.9% |
|
BDX
Becton Dickinson
|
Jul 14, 2025 | HOLD |
Buy
+26.5% avg upside
25 analysts
|
$183.00
17.69% Upside
|
+10.9% |
|
LAB
Standard BioTools
|
May 06, 2025 | BUY |
Buy
+633.3% avg upside
8 analysts
|
$2.50
194.06% Upside
|
-8.5% |
|
LULU
Lululemon Athletica
|
Apr 27, 2023 | BUY |
Buy
+77.0% avg upside
45 analysts
|
$525.00
348.02% Upside
|
-3.5% |
|
VZ
Verizon
|
Apr 26, 2023 | BUY |
Buy
+16.8% avg upside
40 analysts
|
$45.00
5.03% Upside
|
+15.5% |
|
MRVI
Maravai Lifesciences Holdings
|
Oct 15, 2021 | BUY |
Strong Buy
+111.5% avg upside
17 analysts
|
$62.00
822.70% Upside
|
-48.0% |
|
TWST
Twist Bioscience
|
Oct 14, 2021 | BUY |
Strong Buy
-16.7% avg upside
14 analysts
|
— | -75.0% |
|
CRL
Charles River Labs
|
Aug 17, 2021 | BUY |
Strong Buy
-7.9% avg upside
34 analysts
|
$465.00
101.73% Upside
|
-47.3% |
|
MTD
Mettler-Toledo
|
May 07, 2021 | SELL |
Buy
-11.0% avg upside
18 analysts
|
$1139.00
13.93% Downside
|
-2.9% |
|
IQV
IQVIA Holdings
|
Apr 23, 2021 | BUY |
Strong Buy
+8.9% avg upside
38 analysts
|
$275.00
31.90% Upside
|
-1.8% |
|
ICLR
Icon
|
Mar 01, 2021 | BUY |
Strong Buy
+9.7% avg upside
25 analysts
|
$232.00
37.30% Upside
|
+33.7% |
|
VCYT
Veracyte
|
Nov 26, 2013 | BUY |
Strong Buy
-14.3% avg upside
18 analysts
|
$16.00
72.59% Downside
|
-48.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.